Ionis Pharmaceuticals (IONS) PT Raised to $82 at RBC Capital

October 30, 2025 9:20 AM EDT
Get Alerts IONS Hot Sheet
Price: $61.05 -2.21%

Rating Summary:
    17 Buy, 11 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
RBC Capital analyst Luca Issi raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $82.00 (from $80.00) while maintaining a rating.

You May Also Be Interested In





Related Categories

Analyst PT Change